Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell Carcinoma.
Labaki C, Saad E, Madsen KN, Hobeika C, Bi K, Alchoueiry M, Camp S, Hou Y, Bakouny Z, Matar S, El Ahmar N, Nyman J, Zhang L, Priolo C, Rout R, Daou M, Khabibullin D, Salem S, Schindler N, Saliby RM, Meli K, Wells JC, Pimenta E, Takemura K, Park J, Eid M, Semaan K, Fu J, Denize T, El Hajj Chehade R, Machaalani M, Nawfal R, Khatoun WD, Saleh M, El Masri J, Haddad NR, Xu W, McGregor BA, Hirsch MS, Xie W, Heng DYC, McDermott DF, Signoretti S, Van Allen EM, Shukla SA, Choueiri TK, Henske EP, Braun DA. Labaki C, et al. J Clin Oncol. 2025 Jul 2:JCO2500234. doi: 10.1200/JCO-25-00234. Online ahead of print. J Clin Oncol. 2025. PMID: 40601888
Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection.
Lin EP, Hsu CY, Mishra S, Griffiths EA, Segal BH, Hwang C, Singh SRK, Balanchivadze N, Jani C, Mariano MG, Bhatt PS, Vieira K, Yu PP, Oligino EJ, Wise-Draper T, Ferrara EK, McKay RR, Nonato TK, Labaki C, Saad E, Saliby RM, Morgans AK, Nohria A, Puc M, Accordino MK, Bodin BE, Nanchal R, Singh H, Berg S, Mavromatis B, McManus HD, Halabi S, Choueiri TK, Warner JL, Shyr Y; COVID-19 and Cancer Consortium. Lin EP, et al. Among authors: labaki c. Lancet Reg Health Am. 2025 Mar 6;44:101038. doi: 10.1016/j.lana.2025.101038. eCollection 2025 Apr. Lancet Reg Health Am. 2025. PMID: 40124588 Free PMC article.
Progressive natural killer cell dysfunction in advanced-stage clear-cell renal cell carcinoma and association with clinical outcomes.
Xu W, Birch G, Meliki A, Moritz V, Bharadwaj M, Schindler NR, Labaki C, Saliby RM, Dinh K, Horst JT, Sun M, Kashima S, Hugaboom M, Dighe A, Machaalani M, Lee GM, Hurwitz M, McGregor BA, Hirsch MS, Shukla SA, McDermott DF, Signoretti S, Romee R, Choueiri TK, Braun DA. Xu W, et al. Among authors: labaki c. ESMO Open. 2025 Feb;10(2):104105. doi: 10.1016/j.esmoop.2024.104105. Epub 2025 Jan 14. ESMO Open. 2025. PMID: 39813824 Free PMC article.
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.
Jammihal T, Saliby RM, Labaki C, Soulati H, Gallegos J, Peris A, McCurry D, Yu C, Shah V, Poduval D, El Zarif T, El Ahmar N, Laimon YN, Eid M, Sheshdeh AB, Krajewski KM, Büttner FA, Schwab M, Heng D, Casellas RC, Rai K, Zacharias Millward NM, Msaouel P, Karam J, Signoretti S, Van Allen E, Choueiri TK, Braun DA, Shukla SA. Jammihal T, et al. Among authors: labaki c. Nat Cancer. 2025 Feb;6(2):372-384. doi: 10.1038/s43018-024-00896-w. Epub 2025 Jan 9. Nat Cancer. 2025. PMID: 39789182
Single-cell epigenetic profiling reveals an interferon response-high program associated with BAP1 deficiency in kidney cancer.
Camp SY, He MX, Cuoco MS, Saad E, Pimenta E, Meli K, Bakouny Z, Labaki C, Titchen BM, Kang YJ, Horst J, Trowbridge R, Shannon E, Helvie K, Thorner AR, Vigneau S, Mayorga A, Kodali J, Lachmayr H, Bemus M, Park J, Choueiri T, Bi K, Van Allen EM. Camp SY, et al. Among authors: labaki c. bioRxiv [Preprint]. 2024 Nov 18:2024.11.15.623837. doi: 10.1101/2024.11.15.623837. bioRxiv. 2024. PMID: 39605676 Free PMC article. Preprint.
Artificial Intelligence in Gastrointestinal Endoscopy.
Labaki C, Uche-Anya EN, Berzin TM. Labaki C, et al. Gastroenterol Clin North Am. 2024 Dec;53(4):773-786. doi: 10.1016/j.gtc.2024.08.005. Epub 2024 Sep 23. Gastroenterol Clin North Am. 2024. PMID: 39489586 Review.
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma.
El Zarif T, Semaan K, Eid M, Seo JH, Garinet S, Davidsohn MP, Sahgal P, Fortunato B, Canniff J, Nassar AH, Abou Alaiwi S, Bakouny Z, Lakshminarayanan G, Savignano H, Lyons K, Matar S, Ali A, Saad E, Saliby RM, Cordeiro P, Zhang Z, El Ahmar N, Laimon YN, Labaki C, Shah V, Freeman D, O'Toole J, Lee GM, Hwang J, Pomerantz M, Signoretti S, Van Allen EM, Xie W, Berchuck JE, Viswanathan SR, Braun DA, Choueiri TK, Freedman ML, Baca SC. El Zarif T, et al. Among authors: labaki c. Cell Rep. 2024 Jun 25;43(6):114350. doi: 10.1016/j.celrep.2024.114350. Epub 2024 Jun 12. Cell Rep. 2024. PMID: 38870013 Free PMC article.
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.
Saad E, Gebrael G, Semaan K, Eid M, Saliby RM, Labaki C, Sayegh N, Wells JC, Takemura K, Ernst MS, Lemelin A, Basappa NS, Wood LA, Powles T, Ernst DS, Lalani AA, Agarwal N, Xie W, Heng DYC, Choueiri TK. Saad E, et al. Among authors: labaki c. Oncologist. 2024 Aug 5;29(8):699-706. doi: 10.1093/oncolo/oyae072. Oncologist. 2024. PMID: 38630540 Free PMC article.
72 results